Liver Cancer
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 14, 2006; 12(42): 6779-6785
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6779
A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model
Claudia Esther Carrasco-Legleu, Yesennia Sánchez-Pérez, Lucrecia Márquez-Rosado, Samia Fattel-Fazenda, Evelia Arce-Popoca, Sergio Hernández-García, Saúl Villa-Treviño
Claudia Esther Carrasco-Legleu, Lucrecia Márquez-Rosado, Samia Fattel-Fazenda, Evelia Arce-Popoca, Sergio Hernández-García, Saúl Villa-Treviño, Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav). Ave. IPN #2508. Col. San Pedro Zacatenco, C.P. 07360, México, D.F., México
Yesennia Sánchez-Pérez, Instituto Nacional de Cancerología, San Fernando No. 22, C.P.14080, México, D.F., México
Author contributions: All authors contributed equally to the work.
Supported by grant 31665-N from Conacyt, Mexico City, Mexico. One of us, CECL, is a recipient of a fellowship from Conacyt 1996-2001 (112857), México City, México
Correspondence to: Dr. Villa-Treviño Saúl, Departamento de Biología Celular, Laboratorio 50, Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav). Ave. IPN #2508. Col. San Pedro Zacatenco, C.P. 07360, México, D.F., México. svilla@cell.cinvestav.mx
Telephone: +52-55-50613993 Fax: +52-55-50613393
Received: May 19, 2006
Revised: September 5, 2006
Accepted: September 15, 2006
Published online: November 14, 2006
Abstract

AIM: To study of the effect of caffeic acid phenethyl ester (CAPE) on the initiation period in a medium-term assay of hepatocarcinogenesis.

METHODS: Male Wistar rats were subjected to a carcinogenic treatment (CT) and sacrificed at 25th d; altered hepatic foci (AHF) were generated efficiently. To a second group of rats a single 20 mg/kg doses of CAPE was given 12 h before initiation with CT and were sacrificed at 25th d. We evaluated the expression of preneoplastic markers as γ-glutamyltranspeptidase (GGT) and glutathione S-transferase type pi protein (GSTp) by histochemistry, RT-PCR and Western blot analyses, respectively. We measured thiobarbituric acid reactive substances (TBARS) in homogenates of liver and used Unscheduled DNA Synthesis (UDS) assay by incorporation of [3H] thymidine (3HdT) in primary hepatocyte cultures (PHC).

RESULTS: At 25th d after CT CAPE reduced the observed increase of GGT+AHF by 84% and liver expression of ggt mRNA by 100%. In case of the GSTp protein, the level was reduced by 90%. As indicative of oxidative stress generated by diethylnitrosamine (DEN) 12 h after its administration, we detected a 68% increase of TBARS. When CAPE was administered before DEN, it completely protected from liver TBARS induction. To have an indication of the sole effect of CAPE on initiation, two carcinogens were tested in a UDS assay in PHC, we used methyl-n-nitrosoguanidine as a direct carcinogen and DEN, as indirect carcinogen. In this assay, genotoxic damage caused by carcinogens was abolished at 5μM CAPE concentration.

CONCLUSION: Our results demonstrated that CAPE possesses anti-genotoxic and antineoplastic capabilities, by an anti-oxidative and free-radical scavenging mechanism.

Keywords: Caffeic acid phenethyl ester; Antioxidant; Hepatocarcinogenesis; Initiation